glp-1 news nov 2025 Therapies May Benefit MPN And MDS Patients What's next for GLP-1 innovation:

In skeletal muscle, it inhibits muscle atrophy, preserves muscle strength, and enhances exercise endurance, as well as increases glucose uptake and storage in myocytes [41]

Reviewed by Eric Schmidt, PhD, of The Fisher Center lab at The Rockefeller University

"This drug belongs to the same broad class as Ozempic-style weight loss drugs, and it acts on multiple hormone pathways that are involved in appetite, metabolism and blood sugar," he said

Its disheartening to put in the effortmeal prepping, counting calories, hitting the gymand still not see the scale budge

In 2026, access is not a secondary consideration in GLP-1 therapy

Sports-Nutrition Guidelines (ACSM Position Stand) Thomas DT, Erdman KA, Burke LM